Inventaire - your friends and communities are your best library

In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression

author

Leland W K Chung

published in: PLOS One

date of publication: 2013-01-16

language: English

main subject: prostate cancer

Cites articles 47

Date

Title

Authors

2012-12-01

Combined Dynamic Alterations in Urinary VEGF Levels and Tissue ADAM9 Expression as Markers for Lethal Phenotypic Progression of Prostate Cancer
2012-01-30

Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor
2011-11-15

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

Karim Fizazi, Fred Saad
2011-07-20

REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma

Masaki Mori, Yuichiro Doki, Yukinori Kurokawa, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata
2011-05-01

Abiraterone and increased survival in metastatic prostate cancer

Susan Ellard, Fred Saad
2011-06-09

Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer
2011-02-25

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Karim Fizazi
2011-02-01

Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy
2010-07-29

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Philip W. Kantoff, David F. Penson
2010-08-24

Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration

Jessica L Fry
2010-04-24

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

Mary-Ellen Taplin
2010-03-01

REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells

Marie-Pierre Buisine, Thécla Lesuffleur
2010-03-01

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Philip W. Kantoff, Jeffrey Schlom, James L. Gulley, William Dahut
2009-10-05

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

Tomasz Demkow
2009-07-01

Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9.

Leena Bruckner-Tuderman
2009-05-29

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham
2009-02-01

Reg IV enhances peritoneal metastasis in gastric carcinomas
2009-02-01

UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines
2009-08-27

Reg IV expression and clinicopathologic features of gallbladder carcinoma.
2009-01-01

Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker

Koji Arihiro, Kazuhiro Sentani, Wataru Yasui, Naohide Oue, Akio Matsubara
2008-12-01

Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis

William Douglas Figg, Sr., William Dahut
2008-08-01

Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer

Wataru Yasui, Naohide Oue, Akio Matsubara
2008-03-01

The role of mitochondria in bee venom-induced apoptosis in human breast cancer MCF7 cells

Jing-Gung Chung, Hsu-Feng Lu
2008-01-01

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study

Ian F. Tannock
2007-07-16

Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells
2007-05-01

Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells
2007-01-29

Expression of the REG IV gene in ulcerative colitis

Hiroshi Seno, Tsutomu Chiba, Apichart Nanakin, Shigehiko Fujii, Akira Sekikawa, Naoki Kanda, Hiroshi Hisatsune, Yoshitaka Konda, Takahiro Fujimori
2007-11-26

ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.

Christian Pilarsky, Manfred Dietel, Klaus Jung
2007-07-01

Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer

John Nemunaitis
2006-10-01

Oxidative stress induces ADAM9 protein expression in human prostate cancer cells
2006-08-17

Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.

Hidetoshi Eguchi, Hidewaki Nakagawa
2005-03-01

Reg IV: a promising marker of hormone refractory metastatic prostate cancer

Massimo Loda

Article - wd:Q34558744

Welcome to Inventaire

the library of your friends and communities

learn more